Health & Environmental Research Online (HERO)


Print Feedback Export to File
2325496 
Journal Article 
Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats 
Takagi, A; Sai, K; Umemura, T; Hasegawa, R; Kurokawa, Y 
1991 
Yes 
Cancer Letters
ISSN: 0304-3835
EISSN: 1872-7980 
ELSEVIER SCI IRELAND LTD 
CLARE 
57 
55-60 
English 
To elucidate the relationship between peroxisome proliferation by perfluorinated compounds and oxidative DNA damage, perfluorooctanoic acid (PFOA), perfluorodecanoic acid (PFDA), perfluorobutyric acid (PFBA) and perfluorooctane (PFO) were administered to 6-week-old F-344 male rats. After a single intraperitoneal (i.p.) injection of PFOA, PFBA or PFO in corn oil at a dose of 100 mg/kg, significant increases of liver weight and 8-hydroxydeoxyguanosine (8-OH-dG) levels in liver DNA were observed in PFOA-treated rats. Oral administration of powdered diet containing 0.02% PFOA or 0.01% PFDA for 2 weeks resulted in significant increases of liver weight and 8-OH-dG levels in liver DNA in rats given both chemicals. On the other hand, no increase in 8-OH-dG levels in kidney DNA was found in either of the studies. Our results demonstrate that, as with other peroxisome proliferators (phthalic ester plasticizers and hypolipidemic drugs), PFOA and PFDA induced peroxisome proliferation also leads to organ specific oxidative DNA damage. 
peroxisome proliferators; perfluorooctanoic acid; perfluorodecanoic acid; 8-hydroxydeoxyguanosine; oxidative DNA damage 
IRIS
• SR Automation
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          Other Sources
               ATSDR
               TEDX
     Screened Studies
          Excluded
               Exclude (TIAB)
• Expanded PFAS SEM (formerly PFAS 430)
     Litsearch: September 2019
          PubMed
          Web of Science
          ToxNet
          Other Sources
               PFAS TOX Database
     Screened Studies
          Included
               Include (TIAB)
          Supplemental
     Not prioritized for screening
     Perfluorooctane
     Potassium perfluorooctanoate
     Sodium perfluorooctanoate
• ^Per- and Polyfluoroalkyl Substances (PFAS)
     PFDA (335-76-2)
          Literature Search
               Pubmed
               WOS
               Toxline
     PFBA (375-22-4)
          Literature Search
               Pubmed
               Toxline
               WOS
• PFAS 150
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
          ToxNet
          Other sources
               PFAS TOX Database
               ATSDR
     Screened Studies
          Supplemental
     Ammonium perfluorooctanoate
     Perfluorinated compounds
     Perfluorobutanoic acid
     Perfluorodecanoic acid
     Perfluorooctane
     Perfluorooctanoic acid
• PFBA
     Literature Search
          Pubmed
          Toxline
          WOS
     Screening Results
          In vivo animal studies
               Liver tox
               Genotox
     Scopus: April 2021
     June 2022 Pelch Database
     June 2022 PFAS150
• PFDA
     Literature Search
          Pubmed
          Toxline
          WOS
     Scopus: April 2021
     Screening Results
          In vivo animal studies
               Liver tox
               Genotox
     Title and Abstract Screening
          Full Text Screening
               Studies Meeting PECO
                    Animal health effect studies
     June 2022 Pelch Database
     June 2022 PFAS150
     Submitted to EPA
     Literature Searches (through April 2023 update and post-public comment/peer review)a    
          Other
               Published PFAS SEMs
          Title & Abstract Screening
               Tagged as Supplemental
                    Full Text Screening
                         Studies Meeting PECO
                              Animal health effects studies
• Yale PFAS Liver study